Biblio

Export 9 results:
Author Title Type [ Year(Asc)]
Filters: Author is Verbeek, Marcel M  [Clear All Filters]
2017
L. J. C. van Wa van Doorn, Gispert, J. D., H Kuiperij, B., Claassen, J. A. H. R., Arighi, A., Baldeiras, I., Blennow, K., Bozzali, M., Castelo-Branco, M., Cavedo, E., Emek-Savaş, D. D., Eren, E., Eusebi, P., Farotti, L., Fenoglio, C., Ormaechea, J. Fortea, Freund-Levi, Y., Frisoni, G. B., Galimberti, D., Genc, S., Greco, V., Hampel, H., Herukka, S. - K., Liu, Y., Lladó, A., Lleo, A., Nobili, F. M., Oguz, K. K., Parnetti, L., Pereira, J., Picco, A., Pikkarainen, M., de Oliveira, C. Resende, Saka, E., Salvadori, N., Sánchez-Valle, R., Santana, I., Scarpini, E., Scheltens, P., Soininen, H., Tarducci, R., Teunissen, C., Tsolaki, M., Urbani, A., Vilaplana, E., Visser, P. Jelle, Wallin, A. K., Yener, G., Molinuevo, J. L., Meulenbroek, O., and Verbeek, M. M., Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes., J Alzheimers Dis, vol. 56, no. 2, pp. 543-555, 2017.
S. Hilal, Akoudad, S., van Duijn, C. M., Niessen, W. J., Verbeek, M. M., Vanderstichele, H., Stoops, E., M Ikram, A., and Vernooij, M. W., Plasma Amyloid-β Levels, Cerebral Small Vessel Disease, and Cognition: The Rotterdam Study., J Alzheimers Dis, vol. 60, no. 3, pp. 977-987, 2017.
B. H Kuiperij, Versleijen, A. A. M., Beenes, M., Verwey, N. A., Benussi, L., Paterlini, A., Binetti, G., Teunissen, C. E., Raaphorst, J., Schelhaas, H. J., Küsters, B., Pijnenburg, Y. A. L., Ghidoni, R., and Verbeek, M. M., Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot Study., J Alzheimers Dis, vol. 55, no. 2, pp. 585-595, 2017.
W. M. Freeze, Jacobs, H. I. L., Gronenschild, E. H., Jansen, J. F. A., Burgmans, S., Aalten, P., Clerx, L., Vos, S. J., van Buchem, M. A., Barkhof, F., van der Flier, W. M., Verbeek, M. M., Rikkert, M. Olde, Backes, W. H., and Verhey, F. R., White Matter Hyperintensities Potentiate Hippocampal Volume Reduction in Non-Demented Older Individuals with Abnormal Amyloid-β., J Alzheimers Dis, vol. 55, no. 1, pp. 333-342, 2017.